Cite

Copy

Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Install/Install App' to create a shortcut app

Recovery From Surgery for Arachnoid Cysts of the Head and Spine in Children

This page was last updated on January 25th, 2023

Postoperative Orders 

  • ICU vs. standard care unit: Many hospitals traditionally have all craniotomy patients recover in the intensive care unit. However, this is not always necessary for an otherwise healthy child.
  • Medications and dosages including PRN drugs: Antibiotics are typically given for 24 hours after surgery, although the evidence supporting this practice is sparse. Dexamethasone may be considered for 24 hours if there is significant mass effect preoperatively and/or cerebral retraction intraoperatively. Standard pain medicine for craniotomy should be provided.
  • Imaging optional: Imaging is not typically indicated in the uneventful surgical case.
  • Physical therapy and orthotics: Rehabilitation may be needed in some cases to help with motor functioning.

Postoperative Morbidity

  • Postoperative pain: Headache/incision pain may be treated with nonsteroidal anti-inflammatory agents. Headaches due to brain shift may improve with a short course of steroids.

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.